Cochrane Abstracts
Yttrium‐90 microsphere radioembolisation for unresectable hepatocellular carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Yttrium‐90 Microsphere Radioembolisation for Unresectable Hepatocellular Carcinoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432852/all/Yttrium‐90_microsphere_radioembolisation_for_unresectable_hepatocellular_carcinoma.
Yttrium‐90 microsphere radioembolisation for unresectable hepatocellular carcinoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432852/all/Yttrium‐90_microsphere_radioembolisation_for_unresectable_hepatocellular_carcinoma. Accessed November 22, 2024.
Yttrium‐90 microsphere radioembolisation for unresectable hepatocellular carcinoma. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432852/all/Yttrium‐90_microsphere_radioembolisation_for_unresectable_hepatocellular_carcinoma
Yttrium‐90 Microsphere Radioembolisation for Unresectable Hepatocellular Carcinoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432852/all/Yttrium‐90_microsphere_radioembolisation_for_unresectable_hepatocellular_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Yttrium‐90 microsphere radioembolisation for unresectable hepatocellular carcinoma
ID - 432852
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432852/all/Yttrium‐90_microsphere_radioembolisation_for_unresectable_hepatocellular_carcinoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
